TauroLock™ solutions are antimicrobial (incl. MRSA & VRE), anticoagulant, and thrombolytic.
Fields of application
See where patients benefit from TauroLock™ lock solutions
Intensive care units
Patients in ICU should use TauroLock™ or TauroLock™-HEP100 according to their medical condition.
Discover our product range
TauroLock™ is recommended for instillation in all central-venous access systems. It prevents the formation of bacterial biofilms and improves the patency rate.
TauroLock™-U25.000 ensures a particularly strong protection against catheter-related complications. It contains taurolidine, 4 % citrate, and 25,000 IU of urokinase.
TauroLock™-Hep100 has proven helpful for patients who previously relied on heparin-based lock solutions. Central-venous catheters remain infection-free and work properly at a high patency rate.
TauroLock™-HEP500 meets the particular needs of dialysis patients. It prevents catheter-related infections as well as occlusions.
TauroLock™ at medical conventions
Meet us at public events across the globe
ISN-WCN 23 World Congress of Nephrology Bangkok30 March – 2 April 2023 www.theisn.org
VAS 13th International Congress of Vascular Access Porto26–29 April 2023 vas2023.com
Ernährung/Nutrition Bregenz1–3 June 2023 www.kongress-ernaehrung.de